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INTRODUCTION & OBJECTIVES: The aim of this study is to investigate the efficacy of hemostatic agents (HA) in Nephron Sparing
Surgery (NSS). A three-matched comparison between patients treated with no HA, with Tachosil® and with Floseal® was performed.
MATERIAL & METHODS: Observational multicentre study (RECORd Project) collects the data of 1055 patients who underwent PN
between January 2009 and December 2012 at 19 Italian centres. Surgical technique, including hemostasis on bedside renal parenchyma,
was performed according to surgeon’s and centre’s preference. Cases treated with more than one HA or with HA other than Floseal® or
Tachosil® were excluded.
A tri-match propensity score analysis was applied to create 66 triplets - no HA group, Floseal® group, Tachosil® group balanced for pre and
intra operative variables. The three groups were compared regarding the main intra and post-operative outcomes.
RESULTS: The study excluded 255 patients treated with more than one HA and were submitted 131 cases to no HA group, 200 to
Tachosil® group, 489 to Floseal® group. In the original cohort significant differences among groups in terms of patient, tumor and surgical
features were detected, so that a tri-match analysis for 66 triplets well balanced triplets were performed. The three matched cohorts
presented a significant difference in EBL, lower in the Floseal® group, but this result lost significance if important clinical EBL was
considered (>400 cc). No significant difference was found between three groups regarding medical and surgical post-operative overall
complications, surgical haemorrhagic Clavien 2 and 3 complications, variation of haemoglobin and creatinine values between preoperative
and 3rd post-operative day.
CONCLUSIONS: Since epidemiologic, clinical and surgical features were similar, no differences in terms of overall and bleeding
complications were detected among patients submitted to NSS without using HA, using Floseal® or Tachosil®. There is no clear evidence
that the use of HA, in addition to sutures, can improve haemostasis after PN.
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